Insights gained through analysis of the clinical trial pipeline can help set research priorities, highlight progress and roadblocks, enable greater patient involvement in trial design, and increase awareness of recruitment and funding needs.

pipeline reviews

​​PDTrialTracker.info

Analyzing the Parkinson's disease clinical trial pipeline to facilitate patient collaboration in research.

Suggestions for improving access to PD trial data to facilitate trial awareness, recruitment, and research efforts:

1. adoption of a trial naming convention within the research/media/patient community that includes a trial's ClinicalTrials.gov trial ID # (NCT # - NCT followed by 8 digits) in all trial-related communications (clinic websites, recruiting efforts, media articles, etc.) (benefits: patients and the general public can easily access key trial information directly on ClinicalTrials.gov, easier to identify trial being referenced, easier to follow trial progress)
2. trial teams to register all PD studies (both interventional and observational), as well as RESULTS of completed studies, on ClinicalTrials.gov, whether submission is required or not. (benefits: free and open access to trial data, pipeline transparency, recruitment, collaboration, elimination of duplicate efforts, awareness of study outcomes amongst participants and community at large)

Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateReview article, Journal of Parkinson's Disease, May 2023.

Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update

Review article, Journal of Parkinson's Disease, May 2022.

Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update
Review article, Journal of Parkinson's Disease, August 2021.

Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2020
Review article, Journal of Parkinson's Disease, July 2020.